Literature DB >> 23892888

End of inevitability: programming and reprogramming.

Kursad Turksen1.   

Abstract

Stem cell commitment and differentiation leading to functional cell types and organs has generally been considered unidirectional and deterministic. Starting first with a landmark study 50 years ago, and now with more recent observations, this paradigm has been challenged, necessitating a rethink of what constitutes both programming and reprogramming processes, and how we can use this new understanding for new approaches to drug discovery and regenerative medicine.

Mesh:

Substances:

Year:  2013        PMID: 23892888     DOI: 10.1007/s12015-013-9459-y

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  31 in total

1.  Copy number variation and selection during reprogramming to pluripotency.

Authors:  Samer M Hussein; Nizar N Batada; Sanna Vuoristo; Reagan W Ching; Reija Autio; Elisa Närvä; Siemon Ng; Michel Sourour; Riikka Hämäläinen; Cia Olsson; Karolina Lundin; Milla Mikkola; Ras Trokovic; Michael Peitz; Oliver Brüstle; David P Bazett-Jones; Kari Alitalo; Riitta Lahesmaa; Andras Nagy; Timo Otonkoski
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

Review 2.  Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier.

Authors:  Akira Watanabe; Yasuhiro Yamada; Shinya Yamanaka
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-05       Impact factor: 6.237

3.  Facile and efficient reprogramming of ciliary body epithelial cells into induced pluripotent stem cells.

Authors:  Aiguo Ni; Ming Jing Wu; Yuka Nakanishi; Sai H Chavala
Journal:  Stem Cells Dev       Date:  2013-06-05       Impact factor: 3.272

4.  Standardized generation and differentiation of neural precursor cells from human pluripotent stem cells.

Authors:  O A Kozhich; R S Hamilton; B S Mallon
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

5.  E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming.

Authors:  Torben Redmer; Sebastian Diecke; Tamara Grigoryan; Angel Quiroga-Negreira; Walter Birchmeier; Daniel Besser
Journal:  EMBO Rep       Date:  2011-07-01       Impact factor: 8.807

6.  Probing into the biological processes influenced by ESC factor and oncoprotein HMGA2 using iPSCs.

Authors:  Amir Morshedi; Zhonglu Ren; Jinming Li; Peter Dröge
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

Review 7.  "Seq-ing" insights into the epigenetics of neuronal gene regulation.

Authors:  Francesca Telese; Amir Gamliel; Dorota Skowronska-Krawczyk; Ivan Garcia-Bassets; Michael G Rosenfeld
Journal:  Neuron       Date:  2013-02-20       Impact factor: 17.173

8.  A stochastic model of epigenetic dynamics in somatic cell reprogramming.

Authors:  Max Flöttmann; Till Scharp; Edda Klipp
Journal:  Front Physiol       Date:  2012-06-27       Impact factor: 4.566

9.  Patient-derived stem cells: pathways to drug discovery for brain diseases.

Authors:  Alan Mackay-Sim
Journal:  Front Cell Neurosci       Date:  2013-03-27       Impact factor: 5.505

Review 10.  Induced pluripotent stem cell technology and direct conversion: new possibilities to study and treat Parkinson's disease.

Authors:  Reinhard Roessler; Erik Boddeke; Sjef Copray
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

View more
  1 in total

Review 1.  Obesity subtypes, related biomarkers & heterogeneity.

Authors:  Laura Perez-Campos Mayoral; Gabriel Mayoral Andrade; Eduardo Perez-Campos Mayoral; Teresa Hernandez Huerta; Socorro Pina Canseco; Francisco J Rodal Canales; Héctor Alejandro Cabrera-Fuentes; Margarito Martinez Cruz; Alma Dolores Pérez Santiago; Juan José Alpuche; Edgar Zenteno; Hector Martínez Ruíz; Ruth Martínez Cruz; Julia Hernandez Jeronimo; Eduardo Perez-Campos
Journal:  Indian J Med Res       Date:  2020-01       Impact factor: 2.375

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.